PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT)
CUSIP: 69366J200
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 81,782,297
- Total 13F shares
- 79,829,985
- Share change
- -5,175,149
- Total reported value
- $2,441,610,603
- Put/Call ratio
- 174%
- Price per share
- $30.58
- Number of holders
- 196
- Value change
- -$156,636,791
- Number of buys
- 121
- Number of sells
- 84
Quarterly Holders Quick Answers
What is CUSIP 69366J200?
CUSIP 69366J200 identifies PTCT - PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 69366J200:
Top shareholders of PTCT - PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
9,369,014
|
$272,544,617 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
11%
|
8,901,565
|
$258,946,525 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
9.3%
|
7,565,086
|
$220,068,352 | — | 31 Mar 2024 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
9.1%
|
7,423,970
|
$215,963,287 | — | 31 Mar 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
8.3%
|
6,764,000
|
$196,764,760 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
5%
|
4,109,792
|
$119,553,849 | — | 31 Mar 2024 | |
| Camber Capital Management LP |
13F
|
Company |
4.9%
|
4,000,000
|
$116,360,000 | — | 31 Mar 2024 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
4.6%
|
3,725,626
|
$108,378,460 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
4.5%
|
3,669,816
|
$106,744,465 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
2.5%
|
2,063,041
|
$60,013,863 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
2.1%
|
1,727,062
|
$50,240,234 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
1,663,068
|
$48,385,857 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
2%
|
1,605,841
|
$46,713,915 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.8%
|
1,481,488
|
$43,096,486 | — | 31 Mar 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
1.8%
|
1,435,480
|
$41,758,113 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.6%
|
1,270,000
|
$36,944,300 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.5%
|
1,225,748
|
$35,657,010 | — | 31 Mar 2024 | |
| Blackstone Inc. |
13F
|
Company |
1.3%
|
1,095,290
|
$31,861,986 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1%
|
826,076
|
$24,173,798 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.93%
|
761,400
|
$22,149,000 | — | 31 Mar 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.93%
|
759,381
|
$22,090,393 | — | 31 Mar 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.86%
|
700,000
|
$20,363,000 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.83%
|
675,001
|
$19,635,779 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.78%
|
639,867
|
$18,614,000 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.76%
|
619,293
|
$18,015,233 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.75%
|
617,386
|
$17,959,759 | — | 31 Mar 2024 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.61%
|
500,216
|
$14,551,283 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.59%
|
480,021
|
$13,963,811 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.57%
|
466,660
|
$13,575,139 | — | 31 Mar 2024 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.54%
|
439,365
|
$12,782,000 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.48%
|
393,242
|
$11,439,410 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.47%
|
383,697
|
$11,161,744 | — | 31 Mar 2024 | |
| Stuart Walter Peltz |
3/4/5
|
CHIEF EXECUTIVE OFFICER, Director |
—
mixed-class rows
|
399,365
mixed-class rows
|
$10,876,127 | — | 31 Jan 2023 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.44%
|
360,157
|
$10,476,967 | — | 31 Mar 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.44%
|
357,302
|
$10,393,921 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.41%
|
337,799
|
$9,826,573 | — | 31 Mar 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.37%
|
306,231
|
$8,908,260 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.37%
|
304,630
|
$8,861,687 | — | 31 Mar 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.37%
|
301,790
|
$8,779,069 | — | 31 Mar 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.36%
|
294,304
|
$8,561,303 | — | 31 Mar 2024 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.35%
|
288,702
|
$8,398,341 | — | 31 Mar 2024 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.33%
|
272,895
|
$7,938,516 | — | 31 Mar 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.33%
|
270,414
|
$7,866,343 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.29%
|
238,209
|
$6,929,500 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.28%
|
225,460
|
$6,558,631 | — | 31 Mar 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.24%
|
199,670
|
$5,808,400 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.24%
|
196,651
|
$5,720,578 | — | 31 Mar 2024 | |
| PDT Partners, LLC |
13F
|
Company |
0.21%
|
175,239
|
$5,097,703 | — | 31 Mar 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.2%
|
167,048
|
$4,859,426 | — | 31 Mar 2024 | |
| GEORGE KAISER FAMILY FOUNDATION |
13F
|
Individual |
0.03%
|
24,380
|
$4,606,357 | — | 31 Mar 2024 |
Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) as of Q2 2024
As of 30 Jun 2024,
PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) was held by
196 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
79,829,985 shares.
The largest 10 holders included
VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., RTW INVESTMENTS, LP, ARMISTICE CAPITAL, LLC, COWEN AND COMPANY, LLC, Camber Capital Management LP, JANUS HENDERSON GROUP PLC, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
197
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
179
Q2 2024 holders
196
Holder diff
17
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.